Technology
‘Control: Ultimate Edition’ headlines February’s batch of PS Plus freebies – Yahoo Finance Australia
The messy next-gen upgrade saga just took another twist.
NEW YORK, Jan. 27, 2021 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that an analyst note commenting on the listing of Intercepts product on the U.S. Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) website reached a conclusion regarding the status of a newly identified safety signal (NISS)…
Continue Reading
